Alari-Pahissa E - Search Results

1

CD69 Targeting Enhances Anti-vaccinia Virus Immunity.

Notario L, Redondo-Antón J, Alari-Pahissa E, Albentosa A, Leiva M, Lopez D, Sabio G, Lauzurica P. Notario L, et al. Among authors: alari pahissa e. J Virol. 2019 Sep 12;93(19):e00553-19. doi: 10.1128/JVI.00553-19. Print 2019 Oct 1. J Virol. 2019. PMID: 31315995 Free PMC article.

2

CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection.

Vega-Ramos J, Alari-Pahissa E, Valle JD, Carrasco-Marín E, Esplugues E, Borràs M, Martínez-A C, Lauzurica P. Vega-Ramos J, et al. Immunol Cell Biol. 2010 Oct;88(7):707-15. doi: 10.1038/icb.2010.62. Epub 2010 May 4. Immunol Cell Biol. 2010. PMID: 20440294

3

Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.

Kerzerho J, Yu ED, Barra CM, Alari-Pahissa E, Girardi E, Harrak Y, Lauzurica P, Llebaria A, Zajonc DM, Akbari O, Castaño AR. Kerzerho J, et al. J Immunol. 2012 Mar 1;188(5):2254-65. doi: 10.4049/jimmunol.1103049. Epub 2012 Feb 1. J Immunol. 2012. PMID: 22301545 Free PMC article.

4

Differential effect of CD69 targeting on bystander and antigen-specific T cell proliferation.

Alari-Pahissa E, Vega-Ramos J, Zhang JG, Castaño AR, Turley SJ, Villadangos JA, Lauzurica P. Alari-Pahissa E, et al. J Leukoc Biol. 2012 Jul;92(1):145-58. doi: 10.1189/jlb.1011499. Epub 2012 Apr 27. J Leukoc Biol. 2012. PMID: 22544938

5

CD69 does not affect the extent of T cell priming.

Alari-Pahissa E, Notario L, Lorente E, Vega-Ramos J, Justel A, López D, Villadangos JA, Lauzurica P. Alari-Pahissa E, et al. PLoS One. 2012;7(10):e48593. doi: 10.1371/journal.pone.0048593. Epub 2012 Oct 30. PLoS One. 2012. PMID: 23119065 Free PMC article.

6

CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.

Notario L, Alari-Pahissa E, de Molina A, Lauzurica P. Notario L, et al. J Virol. 2016 Jun 24;90(14):6464-6474. doi: 10.1128/JVI.00550-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27147744 Free PMC article.

7

Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR.

Notario L, Alari-Pahissa E, Albentosa A, Leiva M, Sabio G, Lauzurica P. Notario L, et al. Leukemia. 2018 Jun;32(6):1445-1457. doi: 10.1038/s41375-018-0052-x. Epub 2018 Feb 27. Leukemia. 2018. PMID: 29483712

8

The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription through Cooperation between the Transcription Factors Oct1 and RUNX1.

Fontela MG, Notario L, Alari-Pahissa E, Lorente E, Lauzurica P. Fontela MG, et al. Among authors: alari pahissa e. Genes (Basel). 2019 Aug 28;10(9):651. doi: 10.3390/genes10090651. Genes (Basel). 2019. PMID: 31466317 Free PMC article.

9

NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake.

Alari-Pahissa E, Ataya M, Moraitis I, Campos-Ruiz M, Altadill M, Muntasell A, Moles A, López-Botet M. Alari-Pahissa E, et al. PLoS Pathog. 2021 Aug 20;17(8):e1009868. doi: 10.1371/journal.ppat.1009868. eCollection 2021 Aug. PLoS Pathog. 2021. PMID: 34415956 Free PMC article.

10

Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen-Containing Particles.

López-Montañés M, Alari-Pahissa E, Sintes J, Martínez-Rodríguez JE, Muntasell A, López-Botet M. López-Montañés M, et al. J Immunol. 2017 Jul 15;199(2):656-665. doi: 10.4049/jimmunol.1601574. Epub 2017 Jun 19. J Immunol. 2017. PMID: 28630095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters